StockStory.org on MSN3d
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top EstimatesBiotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results , with sales up 15.7% year on year to $2.91 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback